These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30424999)

  • 1. Diagnostic Accuracy of CT for Prediction of Bladder Cancer Treatment Response with and without Computerized Decision Support.
    Cha KH; Hadjiiski LM; Cohan RH; Chan HP; Caoili EM; Davenport MS; Samala RK; Weizer AZ; Alva A; Kirova-Nedyalkova G; Shampain K; Meyer N; Barkmeier D; Woolen S; Shankar PR; Francis IR; Palmbos P
    Acad Radiol; 2019 Sep; 26(9):1137-1145. PubMed ID: 30424999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraobserver Variability in Bladder Cancer Treatment Response Assessment With and Without Computerized Decision Support.
    Hadjiiski LM; Cha KH; Cohan RH; Chan HP; Caoili EM; Davenport MS; Samala RK; Weizer AZ; Alva A; Kirova-Nedyalkova G; Shampain K; Meyer N; Barkmeier D; Woolen SA; Shankar PR; Francis IR; Palmbos PL
    Tomography; 2020 Jun; 6(2):194-202. PubMed ID: 32548296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Learning Approach for Assessment of Bladder Cancer Treatment Response.
    Wu E; Hadjiiski LM; Samala RK; Chan HP; Cha KH; Richter C; Cohan RH; Caoili EM; Paramagul C; Alva A; Weizer AZ
    Tomography; 2019 Mar; 5(1):201-208. PubMed ID: 30854458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial phase CT for assessment of pathologic complete response after neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Choi SJ; Park KJ; Lee G; Kim MH; Kim JK
    Eur J Radiol; 2020 May; 126():108902. PubMed ID: 32126443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized Decision Support for Bladder Cancer Treatment Response Assessment in CT Urography: Effect on Diagnostic Accuracy in Multi-Institution Multi-Specialty Study.
    Sun D; Hadjiiski L; Alva A; Zakharia Y; Joshi M; Chan HP; Garje R; Pomerantz L; Elhag D; Cohan RH; Caoili EM; Kerr WT; Cha KH; Kirova-Nedyalkova G; Davenport MS; Shankar PR; Francis IR; Shampain K; Meyer N; Barkmeier D; Woolen S; Palmbos PL; Weizer AZ; Samala RK; Zhou C; Matuszak M
    Tomography; 2022 Mar; 8(2):644-656. PubMed ID: 35314631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Response Assessment for Bladder Cancer on CT Based on Computerized Volume Analysis, World Health Organization Criteria, and RECIST.
    Hadjiiski L; Weizer AZ; Alva A; Caoili EM; Cohan RH; Cha K; Chan HP
    AJR Am J Roentgenol; 2015 Aug; 205(2):348-52. PubMed ID: 26204286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Choi SJ; Park KJ; Heo C; Park BW; Kim M; Kim JK
    Clin Radiol; 2021 Aug; 76(8):627.e13-627.e21. PubMed ID: 33762138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
    van de Putte EEF; Vegt E; Mertens LS; Bruining A; Hendricksen K; van der Heijden MS; Horenblas S; van Rhijn BWG
    Int Urol Nephrol; 2017 Sep; 49(9):1585-1591. PubMed ID: 28674853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response.
    Ghodoussipour S; Xu W; Tran K; Atkinson R; Cho D; Miranda G; Cai J; Bhanvadia S; Schuckman A; Daneshmand S; Djaladat H
    Urol Oncol; 2021 Feb; 39(2):133.e1-133.e8. PubMed ID: 32900621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
    Seiler R; Ashab HAD; Erho N; van Rhijn BWG; Winters B; Douglas J; Van Kessel KE; Fransen van de Putte EE; Sommerlad M; Wang NQ; Choeurng V; Gibb EA; Palmer-Aronsten B; Lam LL; Buerki C; Davicioni E; Sjödahl G; Kardos J; Hoadley KA; Lerner SP; McConkey DJ; Choi W; Kim WY; Kiss B; Thalmann GN; Todenhöfer T; Crabb SJ; North S; Zwarthoff EC; Boormans JL; Wright J; Dall'Era M; van der Heijden MS; Black PC
    Eur Urol; 2017 Oct; 72(4):544-554. PubMed ID: 28390739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study.
    Mazza P; Moran GW; Li G; Robins DJ; Matulay JT; Herr HW; Decastro GJ; McKiernan JM; Anderson CB
    J Urol; 2018 Nov; 200(5):1005-1013. PubMed ID: 29787740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary bladder cancer staging in CT urography using machine learning.
    Garapati SS; Hadjiiski L; Cha KH; Chan HP; Caoili EM; Cohan RH; Weizer A; Alva A; Paramagul C; Wei J; Zhou C
    Med Phys; 2017 Nov; 44(11):5814-5823. PubMed ID: 28786480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-based radiomics to predict the pathological grade of bladder cancer.
    Zhang G; Xu L; Zhao L; Mao L; Li X; Jin Z; Sun H
    Eur Radiol; 2020 Dec; 30(12):6749-6756. PubMed ID: 32601949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial.
    Hinsenveld FJ; Noordman BJ; Boormans JL; Voortman J; van Leenders GJLH; van der Pas SL; van Beek SC; Oprea-Lager DE; Vis AN
    BMC Cancer; 2021 Oct; 21(1):1161. PubMed ID: 34715822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
    Brant A; Kates M; Chappidi MR; Patel HD; Sopko NA; Netto GJ; Baras AS; Hahn NM; Pierorazio PM; Bivalacqua TJ
    Urol Oncol; 2017 Jan; 35(1):34.e17-34.e25. PubMed ID: 27639777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Krabbe LM; Westerman ME; Margulis V; Raj GV; Sagalowsky AI; Courtney K; Arriaga Y; Lotan Y
    Can J Urol; 2015 Aug; 22(4):7865-75. PubMed ID: 26267024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A deep residual learning network for predicting lung adenocarcinoma manifesting as ground-glass nodule on CT images.
    Gong J; Liu J; Hao W; Nie S; Zheng B; Wang S; Peng W
    Eur Radiol; 2020 Apr; 30(4):1847-1855. PubMed ID: 31811427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study.
    Wei Z; Xv Y; Liu H; Li Y; Yin S; Xie Y; Chen Y; Lv F; Jiang Q; Li F; Xiao M
    Int J Surg; 2024 May; 110(5):2922-2932. PubMed ID: 38349205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.